Open AccessBacillus Calmette–Guérin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy
Author(s) -
James Nuttall,
MaryAnn Davies,
Gregory Hussey,
Brian Eley
Publication year - 2008
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2008.06.014
Subject(s) - medicine , vaccination , stavudine , bcg vaccine , viral load , lamivudine , retrospective cohort study , surgery , immunology , pediatrics , antiretroviral therapy , human immunodeficiency virus (hiv) , hepatitis b virus , virus
To describe the frequency, risk factors, and clinical features of bacillus Calmette-Guérin (BCG) complications in HIV-infected children treated with highly active antiretroviral therapy (HAART).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom